PRMT9 Aggravated Dopaminergic Neurodegeneration in Parkinson's Disease Model by Facilitating the Degradation of DUSP26 and Inducing Mitochondrial Dysfunction
Advanced Science · 2026
DOI: 10.1002/advs.76033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Tengfei Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences and Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.…. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Mitochondria, Dopaminergic Neurons, Parkinson Disease. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Protein arginine methyltransferases (PRMTs) catalyze protein arginine methylation and play a crucial role in the pathogenesis of diseases. Mitochondrial dysfunction is implicated in the neurodegeneration of Parkinson's disease (PD). However, whether protein arginine methyltransferase 9 (PRMT9), which is found in mitochondria, is involved in PD remains unclear. In this study, we found that PRMT9 was markedly increased in the nigrostriatal region of PD mice induced by MPTP and in SH‐SY5Y cells stimulated with MPP + . In MPP + ‐exposed SH‐SY5Y cells, PRMT9 translocated to mitochondria and exacerbated mitochondrial injury, manifested as decreased mitochondrial membrane potential, reduced ATP production, elevated ROS levels, and mitochondrial fragmentation. Furthermore, PRMT9 deficiency significantly alleviated dopaminergic (DA) neurodegeneration induced by MPTP, while PRMT9 overexpression aggravated MPTP‐induced neurodegeneration. Mechanistically, PRMT9 directly interacted with dual‐specificity phosphatase 26 (DUSP26) and catalyzed its arginine methylation at residue R29, which then promoted the polyubiquitination and proteasomal degradation of DUSP26 mediated by Trim32. Therefore, PRMT9 drove DA neurodegeneration in PD by promoting DUSP26 degradation and inducing mitochondrial dysfunction. Our study identified PRMT9 as a novel potential therapeutic target and a pharmaceutical intervention targeting the interaction between PRMT9 and DUSP26 may provide a promising strategy for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences and Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P. R. China.
- Research Center for Basic Medical Sciences, Qilu Hospital, Shandong University, Jinan, Shandong, P. R. China.
- Department of Neurosurgery, The First Medical Centre, Chinese PLA General Hospital, Beijing, P. R. China.
- Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P. R. China.
- Key Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, P. R. China.
- Shenzhen Research Institute of Shandong University, Shenzhen, Guangdong, P. R. China.
ORCID-Profile: Rui Xiao, Ru Sun, Lingjun Kong
Förderung
- National Natural Science Foundation of China
- Shandong Provincial Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Liu, T., Song, X., Guo, X., Xiao, R., Sun, R., Ji, Q., Yu, L., Li, Y., Fu, Q., Xue, Q., Kong, L., Chen, L., Gao, C., & Liu, H. (2026). PRMT9 Aggravated Dopaminergic Neurodegeneration in Parkinson's Disease Model by Facilitating the Degradation of DUSP26 and Inducing Mitochondrial Dysfunction. Advanced Science. https://doi.org/10.1002/advs.76033
Vancouver
Liu T, Song X, Guo X, Xiao R, Sun R, Ji Q, et al. PRMT9 Aggravated Dopaminergic Neurodegeneration in Parkinson's Disease Model by Facilitating the Degradation of DUSP26 and Inducing Mitochondrial Dysfunction. Advanced Science. 2026. doi:10.1002/advs.76033
BibTeX
@article{Liu2026,
author = {Liu, Tengfei and Song, Xiaomeng and Guo, Xin and Xiao, Rui and Sun, Ru and Ji, Qiuran and Yu, Lu and Li, Yiquan and Fu, Qingyi and Xue, Qidi and Kong, Lingjun and Chen, Lin and Gao, Chengjiang and Liu, Huiqing},
title = {PRMT9 Aggravated Dopaminergic Neurodegeneration in Parkinson's Disease Model by Facilitating the Degradation of DUSP26 and Inducing Mitochondrial Dysfunction},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76033}
}
EUVIMED